USPTO serial 79289547
Reviewed by CopyMark Law Group
This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Plus Government fees of $975
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Chemical coating agents for medical devices; flocculants; chemicals for use in the purification of water; chemicals for use in separation and purification techniques; chemicals for use in chromatography; biochemical catalysts; tensio-active chemical agents and surface-active chemical agents for formulating poorly water-soluble substances; solubilizing agent for aerosols; chitosan for use as a raw ingredient in the manufacture of cosmetics or pharmaceuticals; preservatives for use in the pharmaceutical industry; chitosan-based polymers for use in the manufacture of pharmaceutical and cosmetic preparations; solubilizing agent for aerosol pharmaceutical preparations | ACTIVE | — |
| 003 | Non-medicated gels, creams and lotions for use against wrinkles and signs of aging; topical skin sprays for cosmetic purposes; cosmetic preparations for skin care; biopolymer-based non-medicated cosmetics and non-medicated toiletry preparations; biopolymer-based cosmetics, in particular non-medicated gels, creams and lotions, for use against wrinkles and signs of aging; biopolymer-based topical skin sprays for cosmetic purposes; biopolymer-based cosmetic preparations for skin care | ACTIVE | — |
| 005 | Pharmaceutical and veterinary preparations for tissue repair, joint treatment and drug delivery; Pharmaceutical substances and preparations for healthcare, namely, for tissue repair, joint treatment and drug delivery; pharmaceutical preparations for the treatment of eye diseases and conditions; eye drops; Medicated eye wash, namely, collyria; anti-infective preparations for veterinary purposes; biological implants, namely, a vital processed human or animal connective tissue; surgical implants comprised of living tissues; biological tissue cultures for medical use; anti-protozoan agents; anti-inflammatory agents; drug delivery agents, namely, drug delivery agents in the form of powders or suspensions that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; diagnostic reagents and contrast media for medical purposes and use with imaging medical equipment, namely X-ray tomography, NMR tomography, ultrasound tomography, optical, luminescence and fluorescence tomography, EPR tomography and Terahertz tomography; Bandage material for dressings; Bandage material for hemostatic dressings; surgical and medical dressings; pre-filled syringes filled with medicinal products or fillers for medical purposes; injectable soft-tissue dermal fillers, intra-articular fillers and intra-vascular fillers; bone void fillers, intra-articular fillers and intra-vascular fillers comprised of living tissues; topical first aid gels for medical and therapeutic use | ACTIVE | — |
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
| Date | Code | Event | What it means |
|---|---|---|---|
| Mar 23, 2026 | REM3 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED | — |
| Jul 24, 2021 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Jul 1, 2021 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Jul 1, 2021 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Jun 23, 2021 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Jun 4, 2021 | CHLD | CHANGE OF OWNER RECEIVED FROM IB | — |
| Mar 23, 2021 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Jan 11, 2021 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Jan 5, 2021 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jan 5, 2021 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Dec 23, 2020 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Dec 23, 2020 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Dec 16, 2020 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Dec 2, 2020 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Nov 10, 2020 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Nov 9, 2020 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Nov 9, 2020 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Nov 4, 2020 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Nov 4, 2020 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Nov 4, 2020 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Nov 4, 2020 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Nov 4, 2020 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Aug 30, 2020 | RFNT | REFUSAL PROCESSED BY IB | — |
| Aug 12, 2020 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Aug 11, 2020 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Jul 29, 2020 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Jul 28, 2020 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jul 28, 2020 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Jul 23, 2020 | DOCK | ASSIGNED TO EXAMINER | — |
| Jul 23, 2020 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jul 21, 2020 | LIMI | LIMITATION FROM ORIGINAL APPLICATION ENTERED | — |
| Jul 16, 2020 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |